Purchased in January, the stable medical care that is not bad for buying and buying is to pay attent

On the Chinese mask market, if you want to ask which company is the most famous, because the stable medical care of the epidemic is undoubtedly the best of them. As the leader of the Chinese mask market, stable medical care has achieved the high -speed growth of performance under the outlet of the epidemic situation. Today, the rich and stable medical care has also begun to buy the road. Should I look at the stable medical treatment for buying and buying?

1. Stable medical care for buying and buying

According to the Securities Daily, the health care of the medical treatment will be taken again, and the merger project will be the next city! A stable medical publication announcement stated that it obtained 100%equity of Guilin Zizhu Llast Products Co., Ltd. (hereinafter referred to as "Guilin latex") with its own funds of 450 million yuan.

It is reported that Guilin's latex shareholders are China Resources Zizhu Pharmaceutical Co., Ltd., the main business scope includes the production and sales of medical latex gloves, medical examination gloves, and latex condoms.

"The strategy of the one -stop solution of this acquisition and stable medical treatment for medical consumables can be highly consistent. It can use the advantages of both parties in customers, markets, products, research and development and production to form a scale and synergy effect." The person in charge of stable medical care told the "" A reporter from the Securities Daily, as for why the acquisition of 100%equity is mainly because Guilin latex was previously state -owned enterprise. Through this acquisition, I hope to introduce a more market -oriented salary system, employee management, and stable medical corporate culture to Guilin latex, 100 %Of equity acquisition can effectively achieve the above purpose.

The announcement shows that Guilin latex's operating income in 2021 and the first quarter of 2022 was 321 million yuan, 74.987 million yuan, and net profit was 50.8541 million yuan and 9.473 million yuan, respectively.

According to the Securities Times survey, Guilin latex is a latex product enterprise invested by the Ministry of Chemical in 1966. It is a designated production enterprise of the former National Family Planning Commission and a supplier of UN Population Fund condom products. The company's three main products include Gao Bang's disposable rubber sterilization surgery gloves, Gao Bang disposable medical rubber check gloves, and Gao Bang rubber condoms.

Specifically, this acquisition will fill the gaps of stable medical care for latex products, especially medical latex gloves, helping stable medical care to become one of the most comprehensive companies in low -value medical consumables in China. At the same time, Guilin's latex products will enter the channel of stable medical consumer consumer to enrich the product line of stable medical consumer.

However, this is not the first time that the stable medical treatment is the first time. According to the statistics of the interface, in the past three months, stable medical treatment has frequently shot, basically the rhythm of the company planned to acquire a company in January. On the evening of April 10, stable medical treatment announced that it was planned to use 728 million yuan in its own funds to acquire a total of 55%of the equity of Longtai Medical. Longtai Medical was established in 2012 and its main business is high -end wound dressing. One month later, on the evening of May 18, the stable medical care was announced that it was planned to acquire 65.55%of Hunan Ping An Medical Division for 652 million yuan, and used 100 million yuan to increase the capital capital to Hunan Ping An Medical Division.

For the acquisition of stable medical care during this period of time, major securities companies have basically given a positive evaluation. Within 6 months, a total of 27 institutions have given a positive evaluation of stable medical care, of which 16 institutions "buy", 7 companies, 7 companies The institution "increases its holdings", one agency is "strongly recommended", 1 institution "strong push", 1 institution "recommendation", and 1 institution "better than the city".

2. What should I think of steady medical care?

To be honest, many people will be surprised to see the series of stable medical care. As a mask giant in China, stable medical treatment does not make a mask well. Why do you buy so large -scale at this time? Where is the logic behind a series of acquisitions of stable medical care?

First of all, the mask is not a long time. For most people, everyone is undoubtedly most impressed by the mask of stable medical care. When the epidemic in 2020 was just beginning, the mask of stable medical treatment was difficult to find, and it was difficult to get a pack of stable medical treatment for 10 pieces of stable medical treatment. The masks can be given to others as a gift that can be given as a gift, and the people they receive will be very happy.

Under such a vent, stable medical care has also made great development. In 2020, the total revenue reached 12.53 billion yuan, a 174.0%growth of 2019, and the net profit attributable to the mother reached 3.81 billion yuan, an increase of 597.5%year -on -year.

However, although the mask is a very good track, the threshold of this track is extremely low. At present, the production of Chinese masks has actually shown a trend that is greater than demand. In this case, there are some problems with stable medical care. With the prevention and control of the domestic and foreign epidemic in the normal state, starting from the third quarter of 2021, the performance of stable medical treatment has begun to decline. According to the 2021 annual report, stable medical treatment achieved revenue of 8.037 billion yuan, a year -on -year decrease of 35.87%; net profit was 1.239 billion yuan, a year -on -year decrease of 67.48%.

In the case of decline in its own main business, stable medical care must be tried to try to stabilize its performance. Therefore, the steady medical treatment to diversified development has become an inevitable trend.

Secondly, investment mergers and acquisitions are undoubtedly an effective means of transformation and development. According to the financial report of stable medical care, as of the end of 2021, the stable medical flow assets were 10.346 billion yuan, accounting for 77.98%; of which, monetary funds were 4.274 billion yuan. The greatest feeling is that this company has made great development with the help of the epidemic, and its advantages are obvious, especially at the capital level. Seeing that there are already many friends who have remembered a famous international case, the famous UAE investment case. The UAE had achieved high wealth in a short time with its own petroleum resources, but the UAE did not lie in the oil field in the oil field. Sitting on the mountains and air, instead opened the road of investment wisely, established a famous Abu Dhabi Investment Bureau to maintain its own wealth stability with the help of investment.

The same gameplay, in fact, steady medical care has thought of it. This is to use investment mergers and acquisitions to continuously expand its own market advantage track. With the help of advantageous tracks borrowing boats to go to sea, it has realized its own industrial transformation. The big hand of monthly medical care continuously invested in, and acquired high -quality assets through investment every month, so as to gradually transform the money you earned by the outbreak into your own market advantages and productivity, thereby solidifying your own wealth, and continuously giving the market to the market Provide more imagination, which may be the core logic of stable medical care.

Moreover, what we see is not to invest in stable medical care. Each of his investment is layout of upstream and downstream related parties in his industry. Every investment is a field of stable medical care. Although the price may not be optimal for mergers and acquisitions, the investment of stable medical care is also paying attention to the place where they are good at. The internalization of the enterprise is its own advantage.

Third, the key to stable medical care is what to do after mergers and acquisitions? From the current point of view, a series of mergers and acquisitions of stable medical treatment is still good, but as we have repeatedly said before, the key to a company's mergers and acquisitions is not just to buy, but after buying Internalization to its own, achieving the effect of 1+1> 2 is the most critical.

For the current stable medical care, although large -scale mergers and acquisitions can effectively improve their market imagination space, so that stable medical care can perform well in many tracks in a short time, but this approach also has a certain hidden danger. This That is, these companies are not very familiar companies with stable medical care. Although stable medical investment is related to the industry upstream and downstream, they are regarded as low -value medical consumables. Medical care is very different, and these companies are also distributed in different regions, and the cultural differences in various places are actually quite large.

Therefore, under such circumstances, the most needed for stable medical care is to quickly integrate the resources of these companies, and use a fusion method according to their actual situation. On the one hand, retaining the advantages of these companies in their own field , To form a complementary advantage of and stable medical care. On the other hand, I feel that the internal management teams of these companies need to be digested so that they can truly fit the needs of stable medical care.

Only by really doing these integrations can we use the advantages of market expansion and sales of stable medical care, and truly transform the assets obtained from mergers and acquisitions into the combat effectiveness of stable medical treatment, which may be the most critical thing at present.

In summary, for the current stable medical care, the acquisition of mergers and acquisitions is smooth. The key to the future is how stable medical care can join forces to jointly hand over a satisfactory answer to the market.

- END -